Overview
Long term follow up of patients included in a randomized controlled trial evaluating awake prone positioning among patients suffering SARS-CoV2 pneumonia (NCT04358939)
Description
All patients included in the initial trial who survived and were not lost to follow up at 28 days will be invited for a telephone interview to collect data on long term quality of life.
Eligibility
Inclusion Criteria:
- Patients included in the randomized meta-trial evaluating awake prone position versus control among COVID-19 patients on high-flow nasal oxygen therapy (Ehrmann 2021).
- Patients alive at D28
- No opposition to participate in the research which evaluates mortality and quality of life by telephone interview.
Exclusion Criteria:
- Patients lost to follow-up after 28 days.
- Withdrawal of consent from randomized meta-trial by patient
- Vulnerable person: safeguard of justice, curatorship, or guardianship
- Patients refusing to answer telephone questionnaire.